Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Executive Officer

CHIEF EXECUTIVE OFFICER

CHIEF FINANCIAL OFFICER

Gain Therapeutics, Inc., a biotechnology company, researches and develops novel therapies to treat diseases caused by protein misfolding in Switzerland and Spain. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietary small molecules that bind these sites, restore protein folding, and treat disease. Its lead product candidate includes GT-02287, for the treatment of GBA1 Parkinson's disease. In addition, the company is developing structurally targeted allosteric regulator candidates to treat various diseases, including Morquio B, GM1 gangliosidosis (GM1), neuronopathic Gaucher disease, GBA1 Parkinson's, Krabbe, and Mucopolysaccharidosis type 1 diseases. Gain Therapeutics, Inc. was founded in 2017 and is headquartered in Bethesda, Maryland.

Gain Therapeutics, Inc., a biotechnology company, researches and develops novel therapies to treat diseases caused by protein misfolding i...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-28	Premium	bought	Premium	Premium	Premium	-
2024-03-26	Premium	sold (taxes)	Premium	Premium	Premium	Chief Executive Officer
2024-03-26	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2023-12-21	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2023-12-20	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2023-12-07	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2023-10-01	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2023-09-20	Premium	acquired	Premium	Premium	Premium	-
2023-09-20	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2023-07-01	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2022-05-25	Premium	bought	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2022-05-20	Premium	bought	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2022-05-19	Premium	bought	Premium	Premium	Premium	CHIEF FINANCIAL OFFICER
2022-05-19	Premium	bought	Premium	Premium	Premium	CHIEF FINANCIAL OFFICER
2022-05-19	Premium	bought	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2021-08-16	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2021-08-16	Premium	acquired	Premium	Premium	Premium	-

GANX - Gain Therapeutics, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for GANX